1-10 of 10
Refining Risk Stratification in Cutaneous Squamous Cell Carcinoma
Practical Dermatology: Updates in Skin CancerRefining Risk Stratification in Cutaneous Squamous Cell Carcinoma
Gaurav Singh, MD, MPH, FACMS
Translating 40-GEP Results Into Personalized cSCC Care
Practical Dermatology: Updates in Skin CancerTranslating 40-GEP Results Into Personalized cSCC Care
Gaurav Singh, MD, MPH, FACMS
Using i40-GEP to Escalate and Personalize cSCC Care
Practical Dermatology: Updates in Skin CancerUsing i40-GEP to Escalate and Personalize cSCC Care
Gaurav Singh, MD, MPH, FACMS
Rethinking Risk in T1a Melanoma with New Data on Age, Prognosis, and Gene Expression Profiling
Practical Dermatology: Updates in Skin CancerRethinking Risk in T1a Melanoma with New Data on Age, Prognosis, and Gene Expression Profiling
Hamza D. Bhatti, DO, FAAD
David G. Cotter, MD, PhD
J. Michael Guenther, MD
- advertisement
GEP Testing for Cutaneous Squamous Cell Carcinoma
Practical DermatologyGEP Testing for Cutaneous Squamous Cell Carcinoma
Emily Ruiz, MD, MPH
Using GEP Test Results to Manage Patients
Practical Dermatology: Updates in Skin CancerUsing GEP Test Results to Manage Patients
Jason Rizzo, MD, PhD
The Importance and Utility of GEP Testing
Practical Dermatology: Updates in Skin CancerThe Importance and Utility of GEP Testing
Hadas Skupsky, MD
When and How to Use Ancillary Testing
Practical Dermatology: Updates in Skin CancerWhen and How to Use Ancillary Testing
Hadas Skupsky, MD
- advertisement
